News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TG Therapeutics, Inc.
NEWS
JOBS
NEWS
Business
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
November 4, 2021
·
13 min read
Business
TG Therapeutics to Host Conference Call on Third Quarter 2021 Financial Results and Business UpdateConference call to be held Thursday, November 4, 2021 at 8:30 AM ET
November 1, 2021
·
1 min read
BioForest
Clinical Catch-Up: October 11-15
October 15, 2021
·
11 min read
·
Mark Terry
Drug Development
TG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
October 14, 2021
·
11 min read
Pharm Country
TG Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple Sclerosis
September 30, 2021
·
7 min read
Pharm Country
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
September 29, 2021
·
9 min read
BioMidwest
Clinical Catch-Up: September 20-24
September 24, 2021
·
12 min read
·
Mark Terry
Pharm Country
TG Therapeutics Announces Publication of Results from an Integrated Safety Analysis of UKONIQ® (umbralisib) in Blood Advances
September 23, 2021
·
11 min read
Pharm Country
TG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare ConferenceFireside chat scheduled for 10:40 AM ET on Monday, September 27, 2021
September 23, 2021
·
1 min read
Pharm Country
TG Therapeutics Announces Combination Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
September 20, 2021
·
17 min read
Pharm Country
TG Therapeutics Recaps Schedule of Upcoming Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
September 13, 2021
·
14 min read
Pharm Country
TG Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceFireside chat available for on demand download at 7:00 AM ET on Monday, September 13, 2021
September 9, 2021
·
1 min read
Pharm Country
TG Therapeutics Announces Data Presentations at the Upcoming XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
August 30, 2021
·
5 min read
Business
TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
August 2, 2021
·
12 min read
Business
TG Therapeutics to Host Conference Call on Second Quarter 2021 Financial Results and Business UpdateConference call to be held Monday, August 2, 2021 at 8:30 AM ET
July 28, 2021
·
1 min read
Pharm Country
TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare ConferenceFireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET
July 9, 2021
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details